UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on oral solid and semi-solid drug dosage forms, has appointed Dr. Chi-Chang Wung to the position of Director of Analytical Development. Dr. Wung will oversee UPM's analytical development group.
Originally published on 6/6/2018 at Drug Development & Delivery
Originally published on 5/29/2018 at Pharma's Almanac
Originally published on 5/25/2018 at Pharmaceutical Outsourcing
UPM Pharmaceuticals CEO- Jim Gregory interviewed by Pharma Horizon Journal during DCAT week 2018.
Originally published on 3/12/2018 at Pharma's Almanac
UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on solid oral and semi-solid dosage forms, has appointed Chris Curtin as Chief Operating Officer. Mr. Curtin was promoted from his previous role as Executive Vice President of Quality Operations. Mr. Curtin will lead the organization responsible for Research & Development, Manufacturing, Quality Assurance, Inventory Management, Quality Control and Analytical Services.
Originally published on 9/01/2018 at Drug Development & Delivery